| Stage | NUE | % of rev | STLD | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $10.4B | 100.00% | $6.5B | 100.00% | NUE ×1.60 |
| Gross profit | $2.0B | 19.56% | $1.3B | 19.70% | STLD +0.1pp |
| Operating income | $1.6B | 15.67% | $1.0B | 15.46% | NUE +0.2pp |
| Pre-tax income | $1.6B | 15.63% | $979M | 15.03% | NUE +0.6pp |
| Net income | $1.3B | 12.31% | $756M | 11.61% | NUE +0.7pp |
| Stage | NUE | STLD | Gap · A − B |
|---|---|---|---|
| Revenue | $10.4B100.00% | $6.5B100.00% | NUE ×1.60 |
| Gross profit | 19.56%$2.0B | 19.70%$1.3B | STLD +0.1pp |
| Operating income | 15.67%$1.6B | 15.46%$1.0B | NUE +0.2pp |
| Pre-tax income | 15.63%$1.6B | 15.03%$979M | NUE +0.6pp |
| Net income |
| 12.31%$1.3B |
| 11.61%$756M |
| NUE +0.7pp |
No disclosed counterparties: STLD.
None